Leukoencephalopathy with bilateral anterior temporal lobe cysts

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:139444E75.2
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Leukoencephalopathy with bilateral anterior temporal lobe cysts (also known as van der Knaap disease or megalencephalic leukoencephalopathy with subcortical cysts, MLC) is a rare inherited neurological disorder characterized by progressive white matter deterioration in the brain. The condition is classified among the sphingolipidoses and related disorders (ICD-10: E75.2). It primarily affects the central nervous system, with hallmark features on brain MRI including diffuse swelling and signal abnormality of the cerebral white matter (leukoencephalopathy) along with characteristic cysts in the anterior temporal regions and often the frontoparietal regions. Patients typically present in the first year of life with macrocephaly (abnormally large head), which is often the earliest sign. Over time, affected individuals develop progressive motor deterioration, spasticity, cerebellar ataxia, and seizures. Cognitive decline occurs but is generally slower than motor deterioration, and many patients retain some cognitive abilities for years. The disease is caused by mutations in the MLC1 gene (most commonly) or the GLIALCAM (HEPACAM) gene. MLC1 mutations cause the classic autosomal recessive form (MLC1), while GLIALCAM mutations can cause either an autosomal recessive form (MLC2A, with a progressive course similar to MLC1) or an autosomal dominant form (MLC2B, which may show clinical improvement over time). The MLC1 and GLIALCAM proteins are involved in brain ion and water homeostasis, and their dysfunction leads to vacuolization of myelin and astrocyte swelling. There is currently no cure or disease-specific treatment for this condition. Management is supportive and symptomatic, including antiepileptic medications for seizure control, physical therapy to manage spasticity and motor difficulties, and occupational and speech therapy. The disease follows a slowly progressive course in most cases, with many patients eventually becoming wheelchair-dependent, though life expectancy can extend into adulthood.

Clinical phenotype terms— hover any for plain English:

LeukoencephalopathyHP:0002352Intracranial cystic lesionHP:0010576
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Infantile

Begins in infancy, roughly 1 month to 2 years old

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Leukoencephalopathy with bilateral anterior temporal lobe cysts.

View clinical trials →

No actively recruiting trials found for Leukoencephalopathy with bilateral anterior temporal lobe cysts at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Leukoencephalopathy with bilateral anterior temporal lobe cysts community →

No specialists are currently listed for Leukoencephalopathy with bilateral anterior temporal lobe cysts.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Leukoencephalopathy with bilateral anterior temporal lobe cysts.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Leukoencephalopathy with bilateral anterior temporal lobe cystsForum →

No community posts yet. Be the first to share your experience with Leukoencephalopathy with bilateral anterior temporal lobe cysts.

Start the conversation →

Latest news about Leukoencephalopathy with bilateral anterior temporal lobe cysts

No recent news articles for Leukoencephalopathy with bilateral anterior temporal lobe cysts.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Leukoencephalopathy with bilateral anterior temporal lobe cysts

What is Leukoencephalopathy with bilateral anterior temporal lobe cysts?

Leukoencephalopathy with bilateral anterior temporal lobe cysts (also known as van der Knaap disease or megalencephalic leukoencephalopathy with subcortical cysts, MLC) is a rare inherited neurological disorder characterized by progressive white matter deterioration in the brain. The condition is classified among the sphingolipidoses and related disorders (ICD-10: E75.2). It primarily affects the central nervous system, with hallmark features on brain MRI including diffuse swelling and signal abnormality of the cerebral white matter (leukoencephalopathy) along with characteristic cysts in the

At what age does Leukoencephalopathy with bilateral anterior temporal lobe cysts typically begin?

Typical onset of Leukoencephalopathy with bilateral anterior temporal lobe cysts is infantile. Age of onset can vary across affected individuals.